Health care company Johnson & Johnson is in talks to pay $2.3 billion to buy Dutch biotech Crucell as it seeks to catapult itself into the global vaccine market.
*For more on this story, read the full Reuters article.
Health care company Johnson & Johnson is in talks to pay $2.3 billion to buy Dutch biotech Crucell as it seeks to catapult itself into the global vaccine market.
*For more on this story, read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99